Evaluating the Therapeutic Impact of Immune Checkpoint Inhibitors in the Management of Brain Metastases from Non-Small Cell Lung Cancer

Background: Non-small cell lung cancer (NSCLC) patients often develop brain metastases (BMs), with an incidence rate of 25–40%. These metastases are associated with a poor prognosis. Although immune checkpoint inhibitors (ICIs) have revolutionized NSCLC treatment, their effectiveness against BMs rem...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Keren Rouvinov, Rashad Naamneh, Alexander Yakobson, Arina Soklakova, Wenad Najjar, Mahmoud Abu Amna, Mohnnad Asla, Ashraf Abu Jama, Nashat Abu Yasin, Mhammad Abu Juda, Sofyan Abu Freih, Yotam Malek, Walid Shalata
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	MDPI AG 2026-03-01
Serie:	Biomedicines
Ämnen:	non-small cell lung cancer brain metastases immune checkpoint inhibitors intracranial objective response rate intracranial disease control rate overall survival
Länkar:	https://www.mdpi.com/2227-9059/14/3/566
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!